Supplementary Figure S1 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

Rokavec, Matjaz; Özcan, Elif; Neumann, Jens; Hermeking, Heiko

doi:10.1158/2767-9764.24058533.v1

Supplementary Figure S1 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

journal contribution

posted on 2023-08-30, 14:20 authored by Matjaz Rokavec, Elif Özcan, Jens Neumann, Heiko Hermeking

Supplementary Figure S1 shows pathway analysis and clinico-pathological associations of unfavorable prognostic genes.

Funding

Deutschen Konsortium für Translationale Krebsforschung (DKTK)

History

ARTICLE ABSTRACT

We identified and validated a 15-gene expression signature for robust prognostication and stratification of patients with stage II colorectal cancer, with superior performance when compared with currently used biomarkers. Therefore, the 15-gene expression signature has the potential to improve the prognostication and treatment decisions for patients with stage II colorectal cancer.

Usage metrics

Keywords

Gastrointestinal Cancers Colorectal cancer Biomarkers Prognostic biomarkers Genetic biomarkers

Licence

CC BY

Supplementary Figure S1 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

Funding

Deutschen Konsortium für Translationale Krebsforschung (DKTK)

History

ARTICLE ABSTRACT

Usage metrics

Categories

Keywords

Licence

Exports